February 16-17, 2027 | Miami Beach
Optieum Biotechnologies is developing an innovative cancer immunotherapy utilizing our proprietary Eumbody System™ to discover and engineer CAR-T cells for the treatment of solid tumors, autoimmune diseases, and fibrosis.